NOTE: Magellan Stem Cells does not treat patients. For those seeking more information on osteoarthritis treatment, please contact our collaborative clinical research partner, Melbourne Stem Cell Centre Research.
Magellan is pleased to announce the results of our Phase 1/2 allogeneic (donor) stem cell trial. The findings are published in Osteoarthritis and Cartilage Open the open-access journal of Osteoarthritis Research Society International (OARSI)
NOTE: Magellan Stem Cells does not treat patients. For those seeking more information on osteoarthritis treatment, please contact our collaborative clinical research partner, Melbourne Stem Cell Centre Research